skip navigation

Skip Nav

AIDSinfo Drug Database

AIDSinfo Drug Database

Drugs by class

FDA-approved

Investigational

Tipranavir  Audio icon

Brand Name: Aptivus
Other Names: TPV
Drug Class: Protease Inhibitors
Approved Use: Treatment of HIV Infection
Drug Image:
Click image to enlarge
Tipranavir
Chemical Image:
Click image to enlarge
tipranavir
tipranavir
Molecular Weight: 602.671

WARNING:

Tipranavir can cause serious, life-threatening side effects. These include liver problems, severe rash, and bleeding in the brain.

Stop taking tipranavir (and ritonavir, the HIV medicine always used with tipranavir) and contact your health care provider right away if you have any of the following symptoms that may signal liver problems:

  • Tiredness.
  • General ill feeling or “flu-like” symptoms.
  • Loss of appetite.
  • Nausea.
  • Yellowing of your skin or the whites of your eyes (jaundice).
  • Dark-colored urine.
  • Light-colored bowel movements.
  • Pain, aching, or tenderness on the right side below your ribs.

Stop taking tipranavir and contact your health care provider right away if you develop a rash and one or more of the following symptoms:

  • Joint pain or stiffness.
  • Throat tightness.
  • Generalized itching.
  • Muscle aches.
  • Fever.
  • Redness, blisters, or peeling of your skin.

Report any unusual or unexplained bleeding to your health care provider.

While taking tipranavir, it is important to keep all of your appointments with your health care provider.

What is tipranavir?

Tipranavir is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children 2 years of age and older. Tipranavir is always used with the HIV medicine ritonavir (brand name: Norvir) and at least two other HIV medicines.

Tipranavir belongs to a class (group) of HIV medicines called protease inhibitors (PIs). PIs block an HIV enzyme called protease. (An enzyme is a protein that starts or increases the speed of a chemical reaction.) By blocking protease, PIs prevent HIV from multiplying and can reduce the amount of HIV in the body. 

Tipranavir should be used only in people who have taken HIV medicines before and whose HIV is resistant to more than one PI. 

Tipranavir does not cure HIV/AIDS. People with HIV should stay on continuous HIV treatment as directed by their health care provider and should take steps to avoid passing HIV to others (for example, always using a condom during sex).

What should I tell my health care provider before taking tipranavir?

Before taking tipranavir, tell your health care provider:

  • If you are allergic to tipranavir or any other medicines, including sulfa medicines.
  • If you have hemophilia or another medical condition that increases your chance of bleeding.
  • If you are taking medicines that increase your chance of bleeding.
  • If you have liver problems or are infected with hepatitis B virus (HBV) infection or hepatitis C virus (HCV) infection.
  • If you have diabetes.
  • If you have any other medical conditions.
  • If you are pregnant or plan to become pregnant. Whether tipranavir can harm an unborn baby is unknown.
  • If you are breastfeeding or plan to breastfeed. Do not breastfeed if you are infected with HIV or are taking tipranavir.
  • If you are using hormone-based birth control (such as pills, injections, or implants). Tipranavir may make these forms of birth control less effective. Your health care provider can help you decide how to adjust your birth control while you are taking tipranavir.
  • About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Tipranavir may affect the way other medicines or products work, and other medicines or products may affect how tipranavir works. Taking tipranavir together with certain medicines or products may cause serious and/or life-threatening side effects.

How should I take tipranavir?

Tipranavir comes in the following forms and strengths:

  • 250-mg capsules (brand name: Aptivus).
  • 100-mg/mL oral solution (brand name: Aptivus).

Take tipranavir according to your health care provider’s instructions.

Tipranavir capsules should be swallowed whole. Do not chew the capsules.

Tipranavir is always used with the HIV medicine ritonavir (brand name: Norvir) and at least two other HIV medicines. Take tipranavir and ritonavir at the same time. If you are taking tipranavir with ritonavir capsules or oral solution, the medicines can be taken with or without meals. If you are taking tipranavir with ritonavir tablets, the medicines must be taken only with meals.

The oral solution of tipranavir contains vitamin E. If you are taking the oral solution, don’t take additional vitamin E other than that contained in a standard multivitamin. 

If you take too much tipranavir, contact your health care provider or local poison control center (1-800-222-1222) right away or go to the nearest hospital emergency room.

For more information on how to take tipranavir, see the FDA drug label from DailyMed. (DailyMed is a federal website that includes the most recent drug labels submitted to FDA.)

What should I do if I forget a dose?

Take the missed dose of tipranavir, together with ritonavir, as soon as you remember it. But if it is almost time for your next dose, skip the missed dose and just take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.

What side effects can tipranavir cause?

Tipranavir can cause serious, life-threatening side effects. These include liver problems, severe rash, and bleeding in the brain. (See the WARNING above.)

Other possible side effects of tipranavir include:

  • Diabetes and high blood sugar (hyperglycemia).
  • Changes in body fat (lipodystrophy).
  • Changes in the immune system (immune reconstitution inflammatory syndrome [IRIS]).
  • Increases in certain fat (cholesterol and triglyceride) levels in the blood (hyperlipidemia).
  • Increased bleeding in people with hemophilia.

Tell your health care provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of tipranavir. Ask your health care provider or pharmacist for more information on possible side effects of tipranavir. You may also want to read this fact sheet about HIV medicines and side effects.

You may report side effects to FDA at 1-800-FDA-1088 (1-800-332-1088).

How should tipranavir be stored?

  • Store tipranavir capsules in a refrigerator at about 36°F to 46°F (2°C to 8°C). You can take the bottle with you for use away from home as long as the bottle remains at a temperature of 59°F to 86°F (15°C to 30°C). Once the bottle is opened, the capsules must be used within 60 days. Keep tipranavir capsules in the container that they came in and keep the container tightly closed.
  • Store tipranavir oral solution at 59°F to 86°F (15°C to 30°C). Do not refrigerate or freeze the oral solution. Once the bottle is opened, the oral solution must be used within 60 days. Keep tipranavir oral solution in the container that it came in and keep the container tightly closed.
  • Safely throw away tipranavir that is no longer needed or expired (out of date).
  • Keep tipranavir and all medicines out of reach of children.

Where can I find more information about tipranavir?

More information about tipranavir is available:

Manufacturer Information

Boehringer Ingelheim
800-243-0127

The above Patient Version drug summary is based on the following FDA label(s): Capsule (liquid filled), solution.

Last Reviewed: March 24, 2014

Last Updated: March 24, 2014


Back to Top